{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:57:28Z","timestamp":1789772248537,"version":"4.0.1"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec id=\"ab-poi240010-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Perinatal stress and fetal growth restriction increase the risk of neonatal hypoglycemia. The underlying pathomechanism is poorly understood. In a sheep model, elevated catecholamine concentrations were found to suppress intrauterine insulin secretion, followed by hyperresponsive insulin secretion once the adrenergic stimulus subsided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether neonates with risk factors for hypoglycemia have higher catecholamine concentrations in umbilical cord blood (UCB) and\/or amniotic fluid (AF) and whether catecholamines are correlated with postnatal glycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In a prospective cohort study of 328 neonates at a tertiary perinatal center from September 2020 through May 2022 in which AF and UCB were collected immediately during and after delivery, catecholamines and metanephrines were analyzed using liquid chromatography with tandem mass spectrometry. Participants received postnatal blood glucose (BG) screenings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Risk factor for neonatal hypoglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Comparison of catecholamine and metanephrine concentrations between at-risk neonates and control participants, and correlation of concentrations of catecholamines and metanephrines with the number and severity of postnatal hypoglycemic episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study of 328 neonates (234 in the risk group: median [IQR] gestational age, 270 [261-277] days; and 94 in the control group: median [IQR] gestational age, 273 [270-278] days), growth-restricted neonates showed increased UCB median (IQR) concentrations of norepinephrine (21.10 [9.15-42.33] vs 10.88 [5.78-18.03] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), metanephrine (0.37 [0.13-1.36] vs 0.12 [0.08-0.28] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and 3-methoxytyramine (0.149 [0.098-0.208] vs 0.091 [0.063-0.149] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001). Neonates with perinatal stress had increased UCB median (IQR) concentrations of norepinephrine (22.55 [8.99-131.66] vs 10.88 [5.78-18.03] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001), normetanephrine (1.75 [1.16-4.93] vs 1.25 [0.86-2.56] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.004), and 3-methoxytyramine (0.120 [0.085-0.228] vs 0.091 [0.063-0.149] nmol\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.008) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.0083 was considered statistically significant). Concentrations of UCB norepinephrine, metanephrine, and 3-methoxytyramine were negatively correlated with AF C-peptide concentration (\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u2009\u22120.212,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.005;\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u2009\u22120.182,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.016; and\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u2009\u22120.183,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.016, respectively [\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.017 was considered statistically significant]). Concentrations of UCB norepinephrine, metanephrine, and 3-methoxytyramine were positively correlated with the number of hypoglycemic episodes (BG concentration of 30-45 mg\/dL) (\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u20090.146,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01;\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u20090.151,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.009; and\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u20090.180,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002, respectively). Concentrations of UCB metanephrine and 3-methoxytyramine were negatively correlated with the lowest measured BG concentration (\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u2009\u22120.149,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01; and\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>s<\/jats:sub>\n                      \u2009=\u2009\u22120.153,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.008, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi240010-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Neonates at risk for hypoglycemia displayed increased catecholamine and metanephrine concentrations that were correlated with postnatal hypoglycemic episodes and lower BG levels; these results are consistent with findings in a sheep model that fetal catecholamines are associated with neonatal \u03b2-cell physiology and that perinatal stress or growth restriction is associated with subsequent neonatal hyperinsulinemic hypoglycemia. Improving the pathomechanistic understanding of neonatal hypoglycemia may help to guide management of newborns at risk for hypoglycemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2024.0304","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T11:00:53Z","timestamp":1711969253000},"page":"577","source":"Crossref","is-referenced-by-count":16,"title":["Association of Fetal Catecholamines With Neonatal Hypoglycemia"],"prefix":"10.1001","volume":"178","author":[{"given":"Henrike","family":"Hoermann","sequence":"first","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"van Faassen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Roeper","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Hagenbeck","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diran","family":"Herebian","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke C.","family":"Muller Kobold","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Dukart","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Medicine, Brain and Behavior (INM-7), Research Centre J\u00fclich, J\u00fclich, Germany"},{"name":"Institute of Systems Neuroscience, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Mayatepek","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meissner","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kummer","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"poi240010r1","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years.","volume":"373","author":"McKinlay","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"poi240010r2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk.","volume":"161","author":"Harris","year":"2012","journal-title":"J Pediatr"},{"issue":"2","key":"poi240010r3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pedn.2004.12.009","article-title":"Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism.","volume":"20","author":"Steinkrauss","year":"2005","journal-title":"J Pediatr Nurs"},{"key":"poi240010r4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.580642","article-title":"Risk factors for adverse neurodevelopment in transient or persistent congenital hyperinsulinism.","volume":"11","author":"Roeper","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"poi240010r5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management.","volume":"166","author":"Stanley","year":"2015","journal-title":"J Pediatr"},{"issue":"3","key":"poi240010r6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1542\/peds.2010-3851","article-title":"Postnatal glucose homeostasis in late-preterm and term infants.","volume":"127","author":"Adamkin","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"poi240010r7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apa.v109.1","article-title":"Swedish national guideline for prevention and treatment of neonatal hypoglycaemia in newborn infants with gestational age =35 weeks.","volume":"109","author":"Wackernagel","year":"2020","journal-title":"Acta Paediatr"},{"issue":"7","key":"poi240010r8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1515\/jpem-2020-0639","article-title":"Challenges in management of transient hyperinsulinism\u2014a retrospective analysis of 36 severely affected children.","volume":"34","author":"Hoermann","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"poi240010r9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2005.10.002","article-title":"Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism.","volume":"148","author":"Hoe","year":"2006","journal-title":"J Pediatr"},{"issue":"15","key":"poi240010r10","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1113\/tjp.2017.595.issue-15","article-title":"Fetal adaptations in insulin secretion result from high catecholamines during placental insufficiency.","volume":"595","author":"Limesand","year":"2017","journal-title":"J Physiol"},{"issue":"5","key":"poi240010r11","doi-asserted-by":"publisher","first-page":"E516","DOI":"10.1152\/ajpendo.00435.2012","article-title":"Reductions in insulin concentrations and \u00df-cell mass precede growth restriction in sheep fetuses with placental insufficiency.","volume":"304","author":"Limesand","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"poi240010r12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1210\/en.2005-0900","article-title":"Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction.","volume":"147","author":"Limesand","year":"2006","journal-title":"Endocrinology"},{"issue":"6","key":"poi240010r13","doi-asserted-by":"publisher","first-page":"R2179","DOI":"10.1152\/ajpregu.2000.279.6.R2179","article-title":"Control of fetal insulin secretion.","volume":"279","author":"Jackson","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"poi240010r14","doi-asserted-by":"publisher","first-page":"E770","DOI":"10.1152\/ajpendo.00494.2009","article-title":"Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction.","volume":"298","author":"Leos","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"poi240010r15","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1152\/ajpregu.00068.2017","article-title":"Enhanced insulin secretion and insulin sensitivity in young lambs with placental insufficiency-induced intrauterine growth restriction.","volume":"313","author":"Camacho","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"poi240010r16","doi-asserted-by":"publisher","first-page":"E58","DOI":"10.1152\/ajpendo.00517.2013","article-title":"Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep.","volume":"306","author":"Chen","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"poi240010r17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/JOE-16-0445","article-title":"Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.","volume":"232","author":"Chen","year":"2017","journal-title":"J Endocrinol"},{"issue":"3","key":"poi240010r18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/uog.2016.48.issue-3","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure.","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"poi240010r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002220","article-title":"The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight.","volume":"14","author":"Kiserud","year":"2017","journal-title":"PLoS Med"},{"issue":"3","key":"poi240010r20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0002-9378(85)90298-4","article-title":"Estimation of fetal weight with the use of head, body, and femur measurements\u2014a prospective study.","volume":"151","author":"Hadlock","year":"1985","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"poi240010r21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1055\/s-2006-924458","article-title":"Analysis of the neonatal collective in the Federal Republic of Germany 12th report: presentation of detailed percentiles for the body measurement of newborns.","volume":"66","author":"Voigt","year":"2006","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"13","key":"poi240010r22","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1021\/acs.analchem.0c01263","article-title":"In matrix derivatization combined with LC-MS\/MS results in ultrasensitive quantification of plasma free metanephrines and catecholamines.","volume":"92","author":"van Faassen","year":"2020","journal-title":"Anal Chem"},{"issue":"8","key":"poi240010r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063009","article-title":"Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-D\u2014a study protocol of a prospective longitudinal study.","volume":"12","author":"Hoermann","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"poi240010r24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"10","key":"poi240010r25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1203\/00006450-198610000-00020","article-title":"Metabolic clearance and plasma appearance rates of catecholamines in preterm and term fetal sheep.","volume":"20","author":"Padbury","year":"1986","journal-title":"Pediatr Res"},{"key":"poi240010r26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2019.03.1620","article-title":"Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: particular importance for early infancy.","volume":"494","author":"Peitzsch","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"11","key":"poi240010r27","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"poi240010r28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1210\/me.2012-1101","article-title":"Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.","volume":"26","author":"Simpson","year":"2012","journal-title":"Mol Endocrinol"},{"issue":"2","key":"poi240010r29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cen.v96.2","article-title":"Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: which is the best diagnostic strategy.","volume":"96","author":"Liu","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"poi240010r30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.901760","article-title":"Biochemical diagnosis of catecholamine-producing tumors of childhood: neuroblastoma, pheochromocytoma and paraganglioma.","volume":"13","author":"Eisenhofer","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"poi240010r31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jmsacl.2021.08.001","article-title":"A high sensitivity LC-MS\/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.","volume":"21","author":"Smy","year":"2021","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"5","key":"poi240010r32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/apa.1984.73.issue-5","article-title":"Catecholamine surge and metabolic adaptation in the newborn after vaginal delivery and caesarean section.","volume":"73","author":"H\u00e4gnevik","year":"1984","journal-title":"Acta Paediatr Scand"},{"issue":"6","key":"poi240010r33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0002-9378(15)33298-1","article-title":"Amniotic fluid catecholamines and metabolites in intrauterine growth retardation.","volume":"141","author":"Divers","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"poi240010r34","first-page":"253","article-title":"Catecholamines in amniotic fluid as indicators of intrapartum fetal stress.","volume":"39","author":"Yashiro","year":"1985","journal-title":"Acta Med Okayama"},{"issue":"23","key":"poi240010r35","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1080\/14767058.2019.1701645","article-title":"Attenuation of sympathoadrenal function during delivery in the fetus of a diabetic mother.","volume":"34","author":"Mahon","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"poi240010r36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1017\/S2040174413000093","article-title":"Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic blockade reveals enhanced \u00df-cell responsiveness in an ovine model of placental insufficiency at 0.7 of gestation.","volume":"4","author":"Macko","year":"2013","journal-title":"J Dev Orig Health Dis"},{"issue":"5","key":"poi240010r37","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1210\/en.2015-1850","article-title":"Adrenal demedullation and oxygen supplementation independently increase glucose-stimulated insulin concentrations in fetal sheep with intrauterine growth restriction.","volume":"157","author":"Macko","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"poi240010r38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1210\/en.2016-1901","article-title":"RNA sequencing exposes adaptive and immune responses to intrauterine growth restriction in fetal sheep islets.","volume":"158","author":"Kelly","year":"2017","journal-title":"Endocrinology"},{"issue":"6","key":"poi240010r39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0092-8674(01)00378-6","article-title":"Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.","volume":"105","author":"Zhang","year":"2001","journal-title":"Cell"},{"issue":"12","key":"poi240010r40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003850","article-title":"Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.","volume":"3","author":"Gonz\u00e1lez-Barroso","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"poi240010r41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nbt.2141","article-title":"Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3.","volume":"30","author":"Blum","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"8","key":"poi240010r42","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1073\/pnas.1400709111","article-title":"Differentiated human stem cells resemble fetal, not adult, \u00df cells.","volume":"111","author":"Hrvatin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"poi240010r43","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2337\/db17-1433","article-title":"Regulation of KATP channel trafficking in pancreatic \u00df-cells by protein histidine phosphorylation.","volume":"67","author":"Srivastava","year":"2018","journal-title":"Diabetes"},{"issue":"9","key":"poi240010r44","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab121","article-title":"Decreased KATP channel activity contributes to the low glucose threshold for insulin secretion of rat neonatal islets.","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"issue":"1","key":"poi240010r45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clp.2021.11.007","article-title":"Advances in understanding the mechanism of transitional neonatal hypoglycemia and implications for management.","volume":"49","author":"Stanescu","year":"2022","journal-title":"Clin Perinatol"},{"key":"poi240010r46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1071206","article-title":"New approaches to screening and management of neonatal hypoglycemia based on improved understanding of the molecular mechanism of hypoglycemia.","volume":"11","author":"Stanley","year":"2023","journal-title":"Front Pediatr"},{"issue":"2","key":"poi240010r47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1471-4159.2003.01696.x","article-title":"Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors.","volume":"85","author":"Schnell","year":"2003","journal-title":"J Neurochem"},{"issue":"5","key":"poi240010r48","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/cancers11050594","article-title":"Impact of extrinsic and intrinsic hypoxia on catecholamine biosynthesis in absence or presence of Hif2a in pheochromocytoma cells.","volume":"11","author":"Bechmann","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"poi240010r49","doi-asserted-by":"publisher","first-page":"C260","DOI":"10.1152\/ajpcell.00315.2015","article-title":"Hypoxia-inducible factor 3 biology: complexities and emerging themes.","volume":"310","author":"Duan","year":"2016","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2817130\/jamapediatrics_hoermann_2024_oi_240010_1716226325.82574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:22:59Z","timestamp":1717413779000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2817130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2024.0304","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}